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This paper analyses the ethical aspects of cross-border reproductive care. Ethical questions are raised by some of
the main reasons of cross-border travelling, i.e. law evasion and unequal access to treatment. The phenomenon
also generates possible conflicts linked to the responsibility of the professionals. Three points are discussed: the
moral obligation of the physician to refer the patient, his/her duty to provide information and counselling and the
acceptability of fee-splitting. The recommendations focus on measures to reduce or limit the number of patients
that have to travel abroad and on steps to guarantee the safety and quality of the treatment wherever it is provided.
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Cross-border reproductive care
Cross-border medical care is a growing phenomenon. It
indicates the movements by candidate health care recipients
from one country or jurisdiction where treatment is unavailable
for them to another country or jurisdiction where they can
obtain the treatment they need. This also applies to persons
looking for infertility treatment. The present document will
focus on the ethical aspects of this phenomenon. We will
avoid the terms ‘reproductive’ or ‘procreative tourism’
because of their negative connotations and will use instead
the neutral term ‘cross-border reproductive care’.
The main causes of cross-border reproductive care are as
follows: a type of treatment is forbidden by law (i.e. sex selec-
tion), certain categories of patients are not eligible for assisted
reproduction (i.e. lesbian couples), the waiting lists are too long
in one’s home country (i.e. oocyte donation), the out-of-pocket
costs for the patients are too high (i.e. absence of insurance), a
technique is not available because of lack of expertise or equip-
ment (i.e. preimplantation genetic diagnosis), a treatment or
technique is not considered safe enough (i.e. cytoplasm trans-
fer) and personal wishes (i.e. privacy considerations). The
different causes of cross-border care can be divided into two
groups: legal restrictions and/or availability. We will analyse
the ethical implications of this complex phenomenon.
Part 1. General ethical principles
Law evasion
Many people are excluded from medically assisted reproduc-
tion in European countries. Restrictions in the law are a
major cause of movements of patients to other countries.
Restrictions may exist in the form of a legal prohibition of
certain treatments. In Italy for instance, no gamete donation
or embryo cryopreservation is allowed. In Germany and
Norway, oocyte donation and surrogacy are forbidden. Other
people are excluded on the basis of personal characteristics
like age, sexual orientation, marital status etc. In France, for
instance, lesbian couples and single women do not have
access to medically assisted reproduction.
Is there a moral imperative to obey the law? In other words,
do citizens in a democracy have the right to obtain treatment
abroad when this treatment is legally forbidden in their own
country? There is a prima facie obligation of citizens to obey
national law. However, there may be very good reasons for
people to bypass the law by travelling abroad. There is a
wealth of precedence in reproductive health care, i.e. termi-
nation of pregnancy, sterilization and contraception. Recent
developments have attributed more value to reproductive
autonomy. This principle justifies transgression in a number
of situations as long as safety, efficacy and welfare of the
patient and the future child is taken into consideration.
Access and distributive justice
Some movements are caused by the lack of provision (i.e.
insufficient number of centres) or availability of the technology
and suboptimal or inadequate reimbursement. These move-
ments, if large scale and long term, indicate a structural
deficit in the national health care system and demand policy
measures. All citizens have a right of access to decent health
care, including reproductive health care in affluent societies
(ESHRE Task Force on Ethics and Law 14, 2008). Normally,
this care should be available in one’s home country.
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Another related reason could be the inability of patients to
pay the high cost of treatment in their own country. This
could be remedied by public funding and/or affordable
private insurance coverage. However, in some circumstances,
cross-border reproductive care can be justified. Two situations
come to mind, i.e. exceptional shortage of material or infra-
structure and highly specialized applications like preimplanta-
tion genetic diagnosis. In those cases, collaboration with
European centres of reference might be the most cost-effective
and safe way to offer quality treatment.
Part II. Consequences of cross-border reproductive care
Effects on legislation
An important question for the evaluation of cross-border repro-
ductive care is what the effect will be on the legislation. At
present, the movements by patients to other countries can be
seen as a form of civil disobedience which intends to change
the existing legislation. However, the phenomenon may have
the opposite effect: politicians may accept the movements of
some citizens to clinics abroad as a safety valve, which
decreases the pressure for law reform internally. In the latter
case, the restrictive legislation will be maintained and patients
will continue to seek care abroad. One condition should be ful-
filled before cross-border movements of patients embarrass the
government and incite them to change, namely visibility.
Especially for highly personal and private interventions like
infertility treatment, this condition is difficult to fulfil as
patients do not want to go public with their problems.
Resource-poor countries
The movement of people from rich countries to resource-poor
countries for all types of medical care may have undesirable
implications for the health care system in these countries and
for the local patients. The investments of health care resources
(including qualified personnel) in foreign patients come down
to the export of health care capacity. Since these countries
are already struggling to provide basic health care for their
own citizens, the resources could be used more efficiently for
their own people. The second danger is exploitation. Fre-
quently, the welfare level correlates with the risk of exploita-
tion of the most vulnerable groups in the population.
Especially for oocyte donation and surrogacy, this risk of
exploitation is real. A final consequence might be that the
average price for oocytes increases, thus making them inac-
cessible for the local patients.
Part III. Professional responsibilities
Referral
When the physician has a conscientious objection against a
certain treatment, he/she is not obliged to refer the patient to
another clinic but he/she should provide adequate information.
When the physician has no conscientious objection, his or her
rights and duties depend on whether the law is permissive or
prohibitive. If the law is permissive, the doctor has the moral
obligation to refer the patient to a clinic that accepts to
perform the treatment or intervention. If the law is prohibitive,
the physician, taking into account the reproductive autonomy
of the patients and within the boundaries of safety, efficiency
and welfare of the future offspring, is morally allowed to
refer to a centre abroad. When the national legislation also pro-
hibits a referral, the same reasoning applies. Indeed, this might
be considered as the first step in a process of civil disobedience.
The logic of this position would lead to support the physicians
who take the responsibility to give the appropriate treatment to
their patients and thus break the law. It is essential that the
treatment for which the patient is referred is supported by the
guidelines from national and international professional
societies.
Provision of information and counselling
Referral of a patient abroad may mean that the patient receives
little or no information and/or counselling. This may be due to
language problems or inadequate standards of the clinic
abroad. When a physician refers patients to centres abroad,
he or she should also provide counselling in order to make
sure that they know what will happen, what kind of questions
they should ask etc. Referral does not eliminate his or her
responsibility completely. It is also the professional responsi-
bility of the referring physician to gather data to make sure
that patients are treated well by the clinic to which he or she
refers. More specifically, the patients should be informed of
unproven efficiency, premature use of techniques in the
clinic, multiple pregnancy rate etc.
Financial arrangements
Fee-splitting is a practice in which a doctor pays another doctor
a certain amount if the latter refers patients to him or her. The
practice of fee-splitting is morally unacceptable because it
leads to practices which do not have the best interests of the
patient in mind. For instance, the patient may be directed to a
doctor who performs below standard, charges higher prices
or practices in more inconvenient places thus unnecessarily
increasing the costs (time, money etc.) for the patient. Such
practices may generate a conflict of interest. Whenever a con-
flict of interests cannot be avoided, the conflict should be dis-
closed to the patient.
Part IV. Patient responsibility
Patient organizations have an important role in disseminating
accurate information to patients. However, due to the vulner-
ability of the patients and the difficulty of obtaining correct
information, the main responsibility lies with the physician.
Furthermore, these organizations may lobby at national and
international level in order to increase access to adequate
health care.
Part V. Role of the professional societies
It is by excellence the task of a professional society to gather
information to present a state of affairs and to provide a
general picture of the different movements. Second, ESHRE
should present itself, together with the patient organizations
and national professional societies, as the promotor of the
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interests of patients. Different tasks can be distinguished:
inform the law makers, the media and the public of the benefits
of assisted reproduction for infertile people, explain the nega-
tive consequences of restrictive laws, explain the responsibility
of referring professionals, defend ethical pluralism and respect
for different opinions. Educational activities and guidelines are
an essential part of promoting standards. The further develop-
ment of a certification system for fertility clinics and labora-
tories is of paramount importance to achieve this goal.
Recommendations
† Regarding legislation, there are three recommendations:
provide at least partial reimbursement for treatment to
ensure equitable access for all citizens; adopt a less
restrictive legislation not to force large groups of patients
to travel abroad; and extend the portability of health
insurance (at least for treatment that is not prohibited in
the home country) to reproductive health care.
† Systems of control and verification should be installed. A
system of certification may be introduced in order to guar-
antee that all patients get safe and effective treatment
wherever they go. This system should not only include
the technical and medical side but also compliance with
ethical standards, including the provision of psychologi-
cal counselling.
† The government, patients and professional organizations
should organize awareness and information campaigns
to warn the citizens for possible dangers of cross-border
reproductive care.
† All professional parties, referring physicians as well as
doctors abroad, should be aware of their responsibilities
and of the relevant ethical guidelines.
† Professional organizations and referring physicians
should collect follow-up data about the results and com-
plications of treatment abroad. It is the professional
responsibility of the referring physician to make sure
that his/her patients are treated well in the clinics to
which they are directed. Patients should be specifically
informed of success rates and the risks and rates of mul-
tiple pregnancies.
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